研報掘金丨中銀證券:維持老百姓“買入”評級,看好公司未來發展情況
中銀證券研報指出,老百姓2024年利潤總額爲9.16億元,同比減少34.94%;25年一季度利潤總額爲3.66億元,同比減少20.49%。收入基本穩定,利潤短期承壓。2025年一季度公司加盟業務實現配送收入超5.8億元,後續隨着公司對加盟藥店的分級管理以及信息賦能,加盟業務後續值得關注。火炬項目持續提高盈利能力,積極探索第二成長曲線。雖然公司短期利潤承壓,但隨着公司加盟業務及火炬項目的不斷推進,後續公司盈利能力有望持續提升,看好公司未來的發展情況,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.